P3 Health Partners (NASDAQ:PIII) Earns Outperform Rating from William Blair

William Blair reiterated their outperform rating on shares of P3 Health Partners (NASDAQ:PIII – Free Report) in a research report report published on Monday, RTT News reports. William Blair also issued estimates for P3 Health Partners’ Q1 2024 earnings at ($0.19) EPS, Q2 2024 earnings at ($0.17) EPS, Q3 2024 earnings at ($0.12) EPS, Q4 […]

Related Keywords

Nevada ,United States ,William Blair ,Health Partners Price Performance ,Health Partners Inc ,Forum Financial Management ,Nasdaq ,Jpmorgan Chase Co ,Health Partners Daily ,Principal Financial Group Inc ,Health Partners ,Health Partners Company Profile ,Goldman Sachs Group Inc ,Health Partner ,Free Report ,Street Capital ,Financial Group ,Financial Management ,Goldman Sachs Group ,Get Free Report ,Partners Inc ,Partners Daily ,P3 Health Partners ,Nasdaq Piii ,Opiii ,Medical ,Reiterated Rating ,